# Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors

> **NCT01446822** · NA · COMPLETED · sponsor: **Daniel Stephan Engeler** · enrollment: 44 (actual)

## Conditions studied

- Neoplasm of Lateral Wall of Urinary Bladder

## Interventions

- **DEVICE:** Bipolar transurethral resection of the urinary bladder (PlasmaKinetic, Gyrus, Fresenius)
- **DEVICE:** Monopolar transurethral resection of the urinary bladder (Storz GmbH &Co., Erbotom, Purisole)

## Key facts

- **NCT ID:** NCT01446822
- **Lead sponsor:** Daniel Stephan Engeler
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2016-06
- **Final completion:** 2016-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2018-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01446822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01446822, "Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01446822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*